PHATHOM PHARMACEUTICALS, INC. (PHAT) Operating cash flow 2018–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$166.8MFY2025 · since FY2018: -$1.0M → -$166.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.8M | +37.5% |
| FY2024 | -$266.8M | -93.9% |
| FY2023 | -$137.6M | +6.1% |
| FY2022 | -$146.5M | +1.3% |
| FY2021 | -$148.5M | -113.0% |
| FY2020 | -$69.7M | -90.9% |
| FY2019 | -$36.5M | -3468.9% |
| FY2018 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice